IEIH

iShares Evolved U.S. Innovative Healthcare ETF
C

--
*Unless otherwise stated, data provided by FactSet.

IEIH Fund Description

IEIH tracks an index that offers US pharmaceutical and biotechnology exposure as defined by the iETF Evolved Sector classification scheme.

IEIH Factset Analytics Insight

IEIH makes use of iShares’ “Evolved” sector classification scheme to provide exposure to a subset of the traditional US healthcare sector. Unlike traditional classification schemes, firms may be classified into more than one sector under the Evolved Sector system. Sector assignments are made using proprietary machine learning models. In this case, IEIH offers exposure to firms traditionally classified as pharmaceuticals and biotechnology. The combination means that the holdings and returns of IEIH may not match those of traditionally classified funds, so investors should use extra caution to be sure that holdings align with their investment objectives.

IEIH MSCI ESG Analytics Insight

iShares Evolved U.S. Innovative Healthcare ETF has an MSCI ESG Fund Rating of BB based on a score of 4.26 out of 10. The MSCI ESG Fund Rating measures the resiliency of portfolios to long-term risks and opportunities arising from environmental, social, and governance factors. ESG Fund Ratings range from best (AAA) to worst (CCC). Highly rated funds consist of companies that tend to show strong and/or improving management of financially relevant environmental, social and governance issues. These companies may be more resilient to disruptions arising from ESG events.

The fund’s Peer Rank reflects the ranking of a fund’s MSCI ESG Fund Quality Score against the scores of other funds within the same peer group, as defined by the Thomson Reuters Lipper Global Classification. iShares Evolved U.S. Innovative Healthcare ETF ranks in the 24th percentile within its peer group and in the 39th percentile within the global universe of all funds covered by MSCI ESG Fund Ratings.

IEIH Charts And Performance

Price Chart ($)
Total Return Chart (%)
  • 1 Month
  • 3 Months
  • YTD
  • 1 Year
  • 3 Years
  • 5 Years
  • Max
  • 1 Month
  • 3 Months
  • YTD
  • 1 Year
  • 3 Years
  • 5 Years
  • Max
Compare
Reset
Select ETFs to compare their performance:
PERFORMANCE [as of 09/18/19] 1 MONTH 3 MONTHS YTD 1 YEAR 3 YEARS 5 YEARS 10 YEARS
IEIH 0.90% -0.58% 6.55% -4.61% -- -- --
IEIH (NAV) 0.61% -2.02% 5.76% -5.80% -- -- --
No Underlying Index -- -- -- -- -- -- --
N/A -- -- -- -- -- -- --
All returns over 1 year are annualized. All returns are total returns unless otherwise stated.

IEIH Summary Data

Blackrock
iShares
03/21/18
Open-Ended Fund
0.18%
$4.98M
$27.20K
0.21%

IEIH Portfolio Data

$105.65B
45.13
4.86
2.01%
09/24/19
222

IEIH Index Data

No Underlying Index
Fundamental
Market Cap
N/A

IEIH Portfolio Management

0.18%
--
--
--

IEIH Tax Exposures

20.00% / 39.60%
0.58%
Qualified dividends
No

IEIH Fund Structure

Open-Ended Fund
No
Yes
72% / 29%
N/A
N/A
High
Daily
Cboe Book Viewer
Top Of Book
Last 10 Trades
Bats BZX Real-time Quote -

IEIH Factset Analytics Block Liquidity

As of 09/19/19
5
4
3
2
1

This measurement shows how easy it is to trade a $1 million USD block of IEIH. IEIH is rated a 4 out of 5.

IEIH Tradability

1,102
$27.20K
769
$19.13K
0.21%
$0.05
0.01%
5.85% / -3.97%
None
100.00%
50,000
0.02
0.08%
0.01%
0
$24.85
4

IEIH Sector/Industry Breakdown


IEIH
Segment Benchmark
63.86%
--
29.69%
--
4.75%
--
1.27%
--
0.24%
--
0.15%
--
0.05%
--

IEIH Top 10 Holdings[View All]

Amgen Inc. 4.66%
57.01%

IEIH Countries


IEIH
Segment Benchmark
100.00%
--

IEIH Regions


IEIH
Segment Benchmark
100.00%
--

IEIH Economic Development


IEIH
Segment Benchmark
100.00%
--

IEIH Performance Statistics

--
--
--
--
0.00%
N/A

IEIH MSCI ESG Ratings

BB
4.26 / 10
38.86
24.36
0.03%
27.84%
25.11

IEIH Benchmark Comparison Holdings

222
--
--
0.00%

IEIH Benchmark Comparison Summary


IEIH
Segment Benchmark
222
--
$105.65B
--
45.13
--
4.86
--
1.66%
--
High
High

IEIH Benchmark Comparison Market Cap Size


IEIH
Segment Benchmark
76.71%
--
15.68%
--
6.42%
--
1.20%
--